trending Market Intelligence /marketintelligence/en/news-insights/trending/VTrcc4yi4R-JaGOdzIAmeA2 content esgSubNav
In This List

AusCann appoints interim CEO

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


AusCann appoints interim CEO

AusCann Group Holdings Ltd tapped Executive Director Paul MacLeman as interim CEO of the company, effective Jan. 1, 2019.

MacLeman will hold the position until the company finds a permanent replacement for Elaine Darby, who previously announced plans to step down as AusCann's managing director.

AusCann is an Australian pharmaceutical company focused on developing cannabinoid medicines.